JayneGurtlerMD

PubMed

• 4 citations
  Supporting Patients with Cancer after Dobbs v. Jackson Women's Health Organization.
  Andrew G Shuman, Matti S Aapro, Benjamin Anderson, Katherine Arbour, Pedro C Barata, Aditya Bardia, Eduardo Bruera, Bruce A Chabner, Herbert Chen, Edwin Choy, Pierfran...> ;The Oncologist. 2022 Aug 13
• 489 citations
  Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study.
  Luc Dirix, István Takács, Guy Jerusalem, Petros Nikolinakos, Hendrik Tobias Arkenau, Andres Forero-Torres, Ralph V. Boccia, Marc E. Lippman, Robert Somer, Martin Smaka...> ;Breast Cancer Research and Treatment. 2018 Oct 23
• 11 citations
  Trabectedin as a Single-Agent Treatment of Advanced Breast Cancer After Anthracycline and Taxane Treatment: A Multicenter, Randomized, Phase II Study Comparing 2 Admin...
  Lori J. Goldstein, Jayne Gurtler, Salvatore Del Prete, Sergei Tjulandin, Vladimir Semiglazov, Eliel Bayever, Bart Michiels> ;Clinical Breast Cancer. 2014 Dec 1
• 25 citations
  A phase 2, single-arm study of ramucirumab in patients with metastatic renal cell carcinoma with disease progression on or intolerance to tyrosine kinase inhibitor the...
  Jorge A. Garcia, Gary R. Hudes, Toni K. Choueiri, Walter M. Stadler, Laura S. Wood, Jayne Gurtler, Shailender Bhatia, Adarsh Joshi, Rebecca R. Hozak, Yihuan Xu, Jonath...> ;Cancer. 2014 Jun 1
• 121 citations
  A phase II and biomarker study of ramucirumab, a human monoclonal antibody targeting the VEGF receptor-2, as first-line monotherapy in patients with advanced hepatocel...
  Andrew X. Zhu, Richard S. Finn, Mary F. Mulcahy, Jayne Gurtler, Weijing Sun, Jonathan D. Schwartz, Rita P. Dalal, Adarsh Joshi, Rebecca R. Hozak, Yihuan Xu, Marek Ancu...> ;Clinical Cancer Research. 2013 Dec 1
• Introduction to the New Section
  Jayne Gurtler, Dwight Kaufman> ;The Oncologist. 2006 May 1
• Trabectedin in third line breast cancer: A multicenter, randomized, phase II study comparing two administration regimens.
  Gurtler JS, Goldstein L, Delprete S, Tjulandin S, Semiglazov V, Sternas L, Michiels B, Gilles E> ;J. Clin. Oncol.. 2005-06-01
• 59 citations
  Randomized Multicenter Phase II Trial of Bolus Plus Infusional Fluorouracil/Leucovorin Compared With Fluorouracil/Leucovorin Plus Oxaliplatin As Third-Line Treatment o...
  Nancy E. Kemeny, Carlos A. Garay, Jayne S. Gurtler, Howard S. Hochster, Peter Kennedy, Al B. Benson, Debra S. Brandt, Jonathan Polikoff, Michael S. Wertheim, Grace Shu...> ;Journal of Clinical Oncology. 2004 Dec 1
• An uncontrolled phase II study evaluating anti-tumor efficacy and safety of ortataxel (BAY 59-8862) in patients with taxane-resistant non-small cell lung cancer.
  Gurtler JS, Von Pawel J, Spiridonidis CH, Grossi F, Larriba JL, Moscovici M, Markovitz E, Voliotis D, Gottfried M> ;J. Clin. Oncol.. 2004-07-15
• 24 citations
  CD20-negative relapse of cutaneous B-cell lymphoma after anti-cd20 monoclonal antibody therapy
  William Trent Massengale, Elizabeth I. McBurney, Jayne Gurtler> ;Journal of the American Academy of Dermatology. 2002 Mar 1
• Join now to see all